ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    iggy and the inhalers
Previous Study | Return to List | Next Study

Iggy and the Inhalers: A Study to Assess the Impact of an Asthma Education Program in School Age Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02839252
Recruitment Status : Withdrawn
First Posted : July 20, 2016
Last Update Posted : February 8, 2018
Sponsor:
Information provided by (Responsible Party):
Jennifer Simonaire, Advocate Health Care

Brief Summary:

The specific aims of this pilot study are to:

  1. Evaluate the effectiveness of the asthma education intervention on asthma knowledge
  2. Determine whether the asthma education intervention improves child and parent asthma treatment self-efficacy

Our hypothesis is that the asthma education intervention will significantly improve asthma knowledge and asthma self-efficacy at 1 month post-intervention as compared to controls.


Condition or disease Intervention/treatment Phase
Asthma Behavioral: Iggy and the Inhalers Asthma Education for Kids Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Iggy and the Inhalers: A Pilot Study to Assess the Impact of an Asthma Education Program in School Age Children
Study Start Date : July 2016
Estimated Primary Completion Date : September 2017
Estimated Study Completion Date : January 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma

Arm Intervention/treatment
Experimental: Intervention Group
After the baseline tools have been completed, the child will be given the Iggy Comic Book and trading cards. Parents and their children will then watch a 12-minute Iggy Video. At the completion of the video and prior to going home, the child and parent will complete the same 2 measures on asthma knowledge and self-efficacy. At 1-month after this clinic visit, the parent will be sent an email with a link to a Qualtrics survey that will contain a few supplemental questions to assess use of the intervention and the same 2 measures that the parent and the child completed at the initial visit.
Behavioral: Iggy and the Inhalers Asthma Education for Kids
It is a comic book, trading cards, and stickers that teach kids about asthma. There is also a 12-minute cartoon video which teaches kids about asthma.

No Intervention: Control Group
After the baseline tools have been completed, the parent and child will go home. At 1-month after the initial study clinic visit, the parent will be sent an email with a link to a Qualtrics survey that will contain a few supplemental questions to assess use of the intervention and the same 2 measures that the parent and the child completed at the initial visit.



Primary Outcome Measures :
  1. Asthma knowledge [ Time Frame: Change in asthma knowledge immediately post-intervention and 1 month after intervention as compared with asthma knowledge prior to the intervention ]
    This will be measured by a 10 question multiple choice survey


Secondary Outcome Measures :
  1. Asthma Self Efficacy [ Time Frame: Change in asthma self efficacy scores immediately post-intervention and 1 month after intervention as compared to pre-intervention self-efficacy scores ]
    This will be measured by a 14 question survey



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   8 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Followed in the Yacktman General Pediatrics Clinic at Advocate Children's Hospital - Park Ridge (ACH-PR)
  • Age 8 - 12 years
  • Documented diagnosis of asthma (any severity level)
  • Child and parent are English-speaking
  • Child is currently taking an asthma medication on either a daily or an as-needed basis
  • Parent permission/consent and child assent is obtained

Exclusion Criteria:

  • Child has a diagnosis of another chronic lung or cardiovascular disease
  • Child was assessed by parents or clinician to have a significant developmental delay, learning, or behavioral disability (e.g., autism spectrum)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02839252


Locations
United States, Illinois
Yacktman Pediatrics
Park Ridge, Illinois, United States, 60068
Sponsors and Collaborators
Advocate Health Care

Responsible Party: Jennifer Simonaire, Pediatric Resident, DO, Advocate Health Care
ClinicalTrials.gov Identifier: NCT02839252     History of Changes
Other Study ID Numbers: 6404
First Posted: July 20, 2016    Key Record Dates
Last Update Posted: February 8, 2018
Last Verified: February 2018

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases